Description
DIVES Trehfill 2 ml is a professional injectable skin booster and biostimulatory formulation developed by DIVES Med. The product is positioned as a contour-stimulating and skin-revitalising injectable, combining a peptide-based complex with trehalose to support dermal quality and tissue conditioning rather than volumisation .
DIVES Trehfill is designed to act through biochemical support mechanisms, aiming to enhance skin firmness, elasticity, and overall tissue vitality. Trehalose, a disaccharide known for its stabilising and protective properties, is combined with peptides to support cellular resilience and dermal structure maintenance. Unlike traditional hyaluronic acid dermal fillers, DIVES Trehfill does not rely on cross-linked HA for mechanical volume or contour shaping.
The product is supplied as a sterile injectable solution and is intended exclusively for administration by qualified medical professionals under aseptic clinical conditions, in accordance with applicable medical-device standards and manufacturer guidance .
What DIVES Trehfill Is Similar To
DIVES Trehfill can be compared to other biostimulatory injectable skin boosters that focus on improving skin firmness and quality rather than providing immediate volumisation. For clinical orientation, products such as Profhilo® or polynucleotide-based injectables are often referenced, as they also aim to enhance tissue quality through biological stimulation rather than mechanical filling.
Profhilo® utilises stabilised hyaluronic acid complexes to remodel tissue hydration and elasticity, whereas DIVES Trehfill relies on a peptide-trehalose combination to support dermal structure and cellular stability. Polynucleotide products act via different biological pathways, focusing on cellular regeneration rather than peptide-mediated stimulation.
While these products share a non-volumising intent, they differ significantly in composition, mechanism of action, and manufacturer-defined indications. Treatment response and longevity may vary depending on patient factors and clinical protocols.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to publicly available manufacturer and distributor information, DIVES Trehfill is indicated for injectable skin revitalisation and contour-supporting treatments.
Specific anatomical treatment areas are not provided by the manufacturer in publicly accessible IFU documentation .
Usage / Administration (IFU-only section)
The following administration parameters are based strictly on publicly available IFU-level information:
-
Injection depth: not provided by manufacturer
-
Volume per point / injection site: not provided by manufacturer
-
Needle gauge: not provided by manufacturer
-
Frequency / number of sessions: not provided by manufacturer
Professional-use disclaimer: DIVES Trehfill is intended for administration only by qualified medical professionals under aseptic clinical conditions [1].
⚠️ Some practitioners apply specific contour-stimulation techniques in clinical practice; these methods are not included in the manufacturer’s official IFU and are therefore not described here.
Ingredient List
Based on publicly available information:
-
Peptide complex (specific composition not disclosed by manufacturer)
-
Trehalose (concentration not provided by manufacturer)
-
Excipients and buffering agents (not provided by manufacturer)
Hyaluronic acid concentration: not provided by manufacturer
Contains lidocaine: not provided by manufacturer
Presentation & Longevity
-
Presentation: 1 × 2 ml sterile prefilled syringe
-
Shelf life: not provided by manufacturer
-
Treatment longevity: not provided by manufacturer
Clinical outcomes and duration of effect may vary depending on patient factors and practitioner-defined protocols.
Safety Notes / Contraindications
Publicly available IFU documentation does not provide a comprehensive contraindication list. Standard safety considerations for injectable skin boosters apply:
-
Use is contraindicated in patients with known hypersensitivity to any component of the product
-
Do not administer in areas with active skin infection, inflammation, or compromised tissue integrity
-
For professional use only; administration must be performed by qualified medical practitioners under aseptic conditions
Regulatory Status
DIVES Trehfill is marketed in the EU and UK as a CE-marked medical-aesthetic injectable device (CE 0318 referenced by distributors).
UKCA status: regulatory classification not specified in public documentation; verify on the product pack or manufacturer’s IFU.
FAQ
Q1: What type of injectable is DIVES Trehfill?
DIVES Trehfill is classified as a biostimulatory skin booster. It is designed to support skin firmness and dermal quality rather than provide immediate volumising or contouring effects .
Q2: Is DIVES Trehfill a dermal filler?
No. DIVES Trehfill does not function as a traditional dermal filler and does not rely on cross-linked hyaluronic acid for volume replacement. It should not be used for wrinkle filling or contour augmentation .
Q3: How is DIVES Trehfill administered?
The manufacturer does not publicly specify injection depth, volume per site, needle gauge, or treatment frequency. The product is intended for professional use only, and clinicians must follow the official IFU supplied with the packaging .
Q4: How long do the effects of DIVES Trehfill last?
The manufacturer does not define a fixed duration of effect. As with other biostimulatory injectables, results may vary depending on patient characteristics, skin condition, and treatment protocol .
Q5: How does DIVES Trehfill differ from HA-based skin boosters?
Unlike HA-based boosters such as Profhilo®, DIVES Trehfill uses a peptide-trehalose formulation. Both aim to improve skin quality, but they differ in composition, biological mechanism, and manufacturer-defined indications .
